SkinMedica Deepens Regenerative Science Commitment with Advisory Board Launch, R&D Expansion, and Flagship Retail Debut
核心洞察
SkinMedica (搜索), an Allergan Aesthetics (搜索) (AbbVie (搜索)) brand, launched a new Regenerative Science Advisory Board comprising leading physicians and skin health experts to bridge breakthrough research with patient care.
The company more than doubled its Irvine, Calif. R&D facility footprint, integrating AI and machine learning to accelerate ingredient discovery and identify novel biological targets for skin longevity.
SkinMedica (搜索) debuted its first in-practice flagship retail experiences at select dermatology practices, with additional locations planned across key U.S. markets throughout 2026.
Allergan Aesthetics (搜索), an AbbVie (搜索) company, announced on July 14, 2026 that its SkinMedica (搜索) brand is significantly expanding its commitment to regenerative science through a trio of strategic initiatives: the formation of a new Regenerative Science Advisory Board, a major expansion of its R&D laboratory in Irvine, California, and the launch of flagship in-practice retail experiences at select medical aesthetics practices nationwide.
"Stemming from its origins in wound-healing research, SkinMedica (搜索) was founded on the principles of regenerative skincare," said Glen Curran, senior vice president, Allergan Aesthetics (搜索). "For more than 25 years, the brand has consistently advanced science-backed solutions, and today we're excited to introduce initiatives that continue to reinforce its mission to support skin health from cell to surface."
Regenerative Science Advisory Board
SkinMedica (搜索) has convened a Regenerative Science Advisory Board composed of leading physicians, clinicians, and skin health experts from across the United States. The board will engage through in-person collaboration, virtual consultations, and curated content across SkinMedica-owned platforms, with the goal of fostering scientific dialogue, sharing clinical best practices, and bridging breakthrough research with everyday patient care.
"Scientific innovation is most impactful when it is informed by the clinicians and experts who bring it to life every day," said Curran. He noted that the advisory board's expertise will help "advance scientific education, strengthen collaboration across the aesthetic community, inform future conversations around skin longevity and innovation; while ensuring we continue to translate breakthrough science into meaningful solutions for providers and patients."
R&D Facility Expansion and AI Integration
The advisory board launch complements SkinMedica (搜索)'s continued investment in innovation, including the recent expansion of its R&D lab in Irvine, California. Now more than double its previous footprint, the enhanced facility brings together formulation scientists, biological researchers, and clinical experts under one roof to streamline and modernize the development of next-generation regenerative skincare products.
The state-of-the-art lab supports a broad range of pre-clinical research and sophisticated imaging technologies that provide deeper insight into skin biology. Notably, SkinMedica (搜索) is leveraging artificial intelligence and machine learning to identify novel biological targets, accelerate ingredient discovery, and advance understanding of the cellular drivers of skin longevity.
"The expanded SkinMedica (搜索) R&D Lab reflects our commitment to advancing the future of skincare through scientific excellence, strategic collaboration, and emerging technologies," said Prithwiraj Maitra, Ph.D., vice president, global skincare R&D, Allergan Aesthetics (搜索). "By integrating advanced research capabilities with AI-enabled discovery and clinical expertise, we are accelerating our ability to transform breakthrough science into meaningful innovations that deliver for patients and providers."
Flagship Retail Experiences
Beyond R&D and education, SkinMedica (搜索) has launched its first in-practice flagship retail experiences at select, highly regarded medical aesthetics practices. These dedicated spaces are designed to extend the physician-guided skincare journey beyond the treatment room, providing an immersive environment where patients can test SkinMedica products, learn about the clinical science behind the brand, and explore personalized regimens recommended by their providers.
The first flagship locations include Lycia Thornburg, M.D. Dermatology in Rapid City, South Dakota and The Skin Clinic in Scottsdale, Arizona, with additional locations planned to open across key U.S. markets throughout 2026.
Most SkinMedica (搜索) products are intended to meet the FDA's definition of a cosmetic product and are not intended to diagnose, treat, cure, or prevent any disease or condition. These products have not been approved by the FDA.